Sirtuin

The author(s) read and approved the final manuscript. Funding This research did not receive any specific grant from funding agencies

CHY drafted the manuscript. ( em P /em 0.05), whereas tumor necrosis factor-, IL-1, IL-18 or transforming growth factor- did

For instance, among 111 individuals seropositive for anti\CEP\1CitCyclic, the vast majority were also seropositive for anti\60\74Cit (88%) and polyclonal. 64%.